Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

REGN

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:REGN
DateTimeSourceHeadlineSymbolCompany
29/10/202022:00PR Newswire (US)FDA Accepts for Priority Review Libtayo® (cemiplimab-rwlc) for Advanced Non-small Cell Lung Cancer with PD-L1 Expression of ...NASDAQ:REGNRegeneron Pharmaceuticals Inc
29/10/202010:26Dow Jones NewsRegeneron: Data Shows REGN-COV2 Reduced Virus Levels, Need for Further Medical AttentionNASDAQ:REGNRegeneron Pharmaceuticals Inc
29/10/202008:00PR Newswire (US)Regeneron's COVID-19 Outpatient Trial Prospectively Demonstrates that REGN-COV2 Antibody Cocktail Significantly Reduced Virus...NASDAQ:REGNRegeneron Pharmaceuticals Inc
29/10/202005:36Dow Jones NewsU.S. Reaches $375 Million Deal for Lilly Covid-19 Antibody DrugNASDAQ:REGNRegeneron Pharmaceuticals Inc
28/10/202007:30PR Newswire (US)Regeneron Announces Investor Conference PresentationsNASDAQ:REGNRegeneron Pharmaceuticals Inc
26/10/202022:59PR Newswire (US)Dupixent® (dupilumab) Late-breaking Pivotal Data Showing Significant Improvement in Eosinophilic Esophagitis Signs and Sympt...NASDAQ:REGNRegeneron Pharmaceuticals Inc
24/10/202007:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
20/10/202001:00Business Wire2nd Annual Gabelli Funds – Columbia Business School Healthcare Symposium (Virtual)NASDAQ:REGNRegeneron Pharmaceuticals Inc
16/10/202023:51Dow Jones NewsRegeneron, Sanofi Get CHMP Backing for Dupixent in Children With Severe Atopic DermatitisNASDAQ:REGNRegeneron Pharmaceuticals Inc
16/10/202022:59PR Newswire (US)CHMP Recommends Approval of Dupixent® (dupilumab) for Children Aged 6 to 11 Years with Severe Atopic DermatitisNASDAQ:REGNRegeneron Pharmaceuticals Inc
15/10/202009:40Dow Jones NewsRegeneron Antibody Cocktail Is First FDA-Approved Ebola TreatmentNASDAQ:REGNRegeneron Pharmaceuticals Inc
15/10/202008:42PR Newswire (US)Regeneron's Antibody Cocktail REGN-EB3 (Inmazeb®) is First FDA-Approved Treatment for Ebola (Zaire Ebolavirus)NASDAQ:REGNRegeneron Pharmaceuticals Inc
13/10/202021:37Dow Jones NewsRegeneron, Sanofi: Dupixent Meets Endpoints in Severe Asthma Attacks in ChildrenNASDAQ:REGNRegeneron Pharmaceuticals Inc
13/10/202015:59PR Newswire (US)Dupixent® (dupilumab) Significantly Reduced Severe Asthma Attacks in Children and is the Only Biologic to Demonstrate Improv...NASDAQ:REGNRegeneron Pharmaceuticals Inc
10/10/202011:30Dow Jones NewsFacebook, Regeneron, Southwest: Stocks That Defined the WeekNASDAQ:REGNRegeneron Pharmaceuticals Inc
10/10/202009:06Dow Jones NewsAntibody Drugs Touted by Trump Could Be Next to Get Authorized for Covid-19NASDAQ:REGNRegeneron Pharmaceuticals Inc
10/10/202002:09Dow Jones NewsCorrection to Covid-19 Antibody Drugs ArticleNASDAQ:REGNRegeneron Pharmaceuticals Inc
09/10/202020:59Dow Jones NewsAntibody Drugs Touted by Trump Could Be Next to Get Authorized for Covid-19NASDAQ:REGNRegeneron Pharmaceuticals Inc
09/10/202000:00Business WireHaeggquist & Eck, LLP Is Investigating Claims Against Regeneron Pharmaceuticals, Inc.’s Directors & Officers for Breach of ...NASDAQ:REGNRegeneron Pharmaceuticals Inc
08/10/202012:45Dow Jones NewsTrump Symptom-Free for 24 Hours, Says White House Doctor-- 4th UpdateNASDAQ:REGNRegeneron Pharmaceuticals Inc
08/10/202011:45Dow Jones NewsTrump Symptom-Free for 24 Hours, Says White House Doctor--3rd UpdateNASDAQ:REGNRegeneron Pharmaceuticals Inc
07/10/202007:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
07/10/202007:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
07/10/202007:05PR Newswire (US)Regeneron to Report Third Quarter 2020 Financial and Operating Results and Host Conference Call and Webcast on November 5, 20...NASDAQ:REGNRegeneron Pharmaceuticals Inc
07/10/202002:55Dow Jones NewsCovid-19 Antibody Drug From Glaxo, Vir Enters Phase 3 TestingNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/10/202007:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
06/10/202002:25Dow Jones NewsTrump's Covid-19 Treatment Seeks to Boost Immune ResponseNASDAQ:REGNRegeneron Pharmaceuticals Inc
03/10/202010:38Dow Jones NewsTrump Received Experimental Antibody Treatment for Coronavirus -- UpdateNASDAQ:REGNRegeneron Pharmaceuticals Inc
03/10/202007:52Dow Jones NewsTrump's Weight, Age, Gender Make Severe Covid-19 More LikelyNASDAQ:REGNRegeneron Pharmaceuticals Inc
30/09/202009:57Dow Jones NewsRegeneron Drug Found to Help Treat Covid-19 in Early Disease Stage -- UpdateNASDAQ:REGNRegeneron Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:REGN